Peptide BPC-157
US$ 27.91
foxo4-dri senolytic human trials Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Peptide Inhibitors Targeting FOXO4-p53 Interactions
Description
Broad Agency Announcements (BAAs) DoD SBIR 24.3 and DoD STTR 24.C are now open for your proposal submissions
Neurogastroenterol Motil 32(9):e13868 Xu XJ, Zhang YL, Liu L, Pan L, Yao SK (2017) Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study
Boi F, Pani F, Mariotti S
Its sequence features 15 amino acids
